Immunoassay Market Poised for Significant Growth Key Players Thermo Fisher Scientific, Inc, F. Hoffmann-La Roche AG, Becton, Dickinson and Company and Others

A new market analysis projects the Immunoassay Market to grow from an estimated USD 34.2 billion in 2025 to USD 55.6 billion by 2035, with a 5.0% CAGR. This growth is driven by rising global health concerns, a surge in infectious and chronic diseases, and increased awareness of antibody testing, particularly post-COVID-19. Immunoassays are essential for disease diagnosis and research.

Click Here for More Information:- https://www.futuremarketinsights.com/reports/immunoassay-market

Reagents & Kits Lead Market Segments

The market is segmented by product type, technology, application, end-use, and region. In 2025, the Reagents & Kits segment dominates with a 48.0% market share due to high-volume demand for diagnostic and research consumables. By technology, Enzyme Immunoassays (EIA/ELISA) are a key growth driver, offering accurate, quantitative results with reduced assay time. The application of immunoassays in infectious disease testing holds the largest share (30%) due to the rising incidence of diseases like HIV and influenza.

North America Leads, Asia-Pacific Fastest Growing

North America is expected to maintain its market leadership with a 35% share in 2025, supported by a strong healthcare infrastructure and a high prevalence of chronic diseases. However, Asia-Pacific is forecasted to be the fastest-growing region, driven by substantial government investments in healthcare in countries like China and India. The region's growing geriatric population and rising chronic diseases also fuel demand for immunoassay kits.

Market Comparison: Immunoassay vs. Blood Glucose

A market comparison highlights the distinct dynamics of the Immunoassay and Blood Glucose Monitoring markets. The Immunoassay market, valued at USD 34.2 billion in 2025, focuses on a broad range of diagnostic applications. In contrast, the Blood Glucose Monitoring Devices market, valued at USD 12.61 billion, has a higher CAGR of 7.8%, driven by the rising prevalence of diabetes and the need for frequent monitoring.

Get Sample Report: - https://www.futuremarketinsights.com/reports/sample/rep-gb-15437

Competitive Landscape & Future Outlook

Key players like Siemens Healthineers, Abbott Laboratories, and bioMérieux SA are driving innovation with automated immunoassay platforms and strategic acquisitions. Challenges include high instrument costs and regulatory hurdles. However, the future remains positive due to rising health awareness and ongoing demand for vaccine monitoring. The market offers opportunities for new players with innovative, user-friendly, and technologically advanced products.

Discover Related Research:-

Foley Catheter Market
https://www.futuremarketinsights.com/reports/foley-catheter-market

Pulse Electromagnetic Field Therapy Devices Market
https://www.futuremarketinsights.com/reports/pulse-electromagnetic-field-therapy-devices-market

Ultrasonic Electrosurgical Devices Market
https://www.futuremarketinsights.com/reports/ultrasonic-electrosurgical-devices-market

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analystsworldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.